Clinical value of percutaneous lung biopsy for pathological diagnosis
经皮肺穿刺活检病理诊断的临床价值研究

摘要

目的 探究肺部疾病诊断中采取经皮肺穿刺活检病变诊断应用价值。方法 选取2020年5月~2023年5月本院收治进行100例CT引导下经皮肺穿刺活检患者为研究对象，完成病理学、细胞学及病原学检查。以手术病理结果和随访结果为基准，探究该检测技术应用价值。结果 最后诊断结果中，良性病变42例，恶性病变58例，以手术病理结果和随访结果为基准，诊断符合率为96.00%；13例患者出现并发症，经对症处理后好转。结论 将经皮肺穿刺活检病理诊断方法应用于肺部疾病诊断中，能够有效区分肺部良恶性病变，为后续个性化治疗提供病理学依据，是一种有价值的诊断方案。

Abstract

Objective To explore the application value of percutaneous lung biopsy in the diagnosis of lung diseases.
Methods From May 2020 to May 2023, 100 patients who underwent CT guided percutaneous lung biopsy in our hospital were selected as the study subjects, and pathological, cytological, and pathogenic examinations were completed. Based on surgical pathological results and follow-up results, explore the application value of this detection technology.
Results Among the final diagnostic results, there were 42 cases of benign lesions and 58 cases of malignant lesions. Based on surgical pathological results and follow-up results, the diagnostic accuracy rate was 96.00%; Thirteen patients experienced complications, which improved after symptomatic treatment.
Conclusion   The application of percutaneous lung biopsy pathological diagnosis method in the diagnosis of lung diseases can effectively distinguish between benign and malignant lung lesions, provide pathological basis for subsequent personalized treatment, and is a valuable diagnostic plan.